What Does Monte Rosa Therapeutics Do?

Total employees188
HeadquartersBoston
FoundedN/A

Monte Rosa Therapeutics is a biopharmaceutical company focused on discovering and developing precision medicines through a novel class of small molecules called molecular glue degraders (MGDs). Their proprietary QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) drug discovery platform enables the rational design and development of MGDs that can selectively degrade disease-causing proteins previously considered undruggable. The company's pipeline targets a range of indications, primarily in oncology and autoimmune/inflammatory diseases, with the goal of transforming patient outcomes.

Where Is Monte Rosa Therapeutics's Headquarters?

HQ Function

The Boston headquarters serves as the central hub for corporate operations, research and development leadership, clinical development, and strategic decision-making.

Notable Features:

Located in a modern life sciences facility within Boston's innovation-rich Seaport District, likely equipped with state-of-the-art laboratories and collaborative office spaces designed to foster scientific discovery.

Work Culture:

The work culture is expected to be dynamic, science-driven, and highly collaborative, characteristic of an innovative biotech company. There's a strong emphasis on cutting-edge research, teamwork, and a shared mission to develop transformative therapies for patients.

HQ Significance:

Boston's Seaport, along with nearby Kendall Square, offers unparalleled access to a dense ecosystem of academic institutions, research organizations, skilled talent, venture capital, and potential collaborators, which is crucial for a company at the forefront of drug discovery.

Values Reflected in HQ: The headquarters' location and design likely reflect Monte Rosa's commitment to innovation, scientific excellence, collaboration, and attracting top-tier talent to advance its pioneering drug discovery platform.

Location:

Monte Rosa Therapeutics operates primarily from its headquarters in Boston, USA, and a significant research facility in Schlieren, Switzerland. This dual presence allows the company to engage with key scientific and biotech hubs in both North America and Europe. Its global functions support comprehensive drug discovery, preclinical development, and planning for international clinical trials and potential future commercialization of its novel molecular glue degraders.

Street Address:

645 Summer Street, Suite 102

City:

Boston

State/Province:

MA

Country:

USA

Where Else Does Monte Rosa Therapeutics Operate Around the World?

Schlieren, Zürich, Switzerland

Address: Monte Rosa Therapeutics AG, Technologiepark, Wagistrasse 27, CH-8952 Schlieren

The Schlieren office enables Monte Rosa to tap into European scientific talent, foster international collaborations, and support its global drug discovery and early development efforts.

Buying Intent Signals for Monte Rosa Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Monte Rosa Therapeutics? Meet the Executive Team

As of April 2025, Monte Rosa Therapeutics' leadership includes:

Markus Warmuth, M.D. - Chief Executive Officer
Silvia Buonamici, Ph.D. - Chief Scientific Officer
Sharon Townson, Ph.D. - Chief Technology Officer
Ajim Tamboli, C.P.A., M.B.A. - Chief Financial Officer
Jullian G. Jones, Ph.D., M.B.A. - Chief Operating Officer
Phil Nickson, Ph.D. - Chief Business Officer

Who's Investing in Monte Rosa Therapeutics?

Monte Rosa Therapeutics has been backed by several prominent investors over the years, including:

Versant Ventures
New Enterprise Associates (NEA)
GV (Google Ventures)
Fidelity Management & Research Company
BlackRock
Cormorant Asset Management
RTW Investments
Longitude Capital

What Leadership Changes Has Monte Rosa Therapeutics Seen Recently?

Hire3
Exits1

Over the past 12 months, Monte Rosa Therapeutics has made significant additions to its executive team, appointing a new Chief Scientific Officer, Chief Operating Officer, and Chief Business Officer, while its former Chief Scientific Officer transitioned out of the company. These changes aim to strengthen leadership as the company advances its pipeline.

Departures

Owen Wallace, Ph.D., Dr. Owen Wallace departed from his role as Chief Scientific Officer.

New Appointments:

Silvia Buonamici, Ph.D., Dr. Silvia Buonamici appointed as Chief Scientific Officer.
Jullian G. Jones, Ph.D., M.B.A., Dr. Jullian G. Jones appointed as Chief Operating Officer.
Phil Nickson, Ph.D., Dr. Phil Nickson appointed as Chief Business Officer.

What Technology (Tech Stack) Is Used byMonte Rosa Therapeutics?

Discover the tools Monte Rosa Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Monte Rosa Therapeutics Email Formats and Examples

Monte Rosa Therapeutics commonly uses the email format of the employee's first initial followed by their last name @monterosatx.com. Other variations might exist but this is the most prevalent pattern.

flast@monterosatx.com

Format

jdoe@monterosatx.com

Example

90%

Success rate

What's the Latest News About Monte Rosa Therapeutics?

GlobeNewswireMay 9, 2024

Monte Rosa Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Monte Rosa announced its Q1 2024 financial results, detailing progress with its lead clinical candidate MRT-2359 for MYC-driven tumors and discovery programs. The company confirmed its cash runway is expected to extend into the second half of 2026....more

GlobeNewswireApril 8, 2024

Monte Rosa Therapeutics Presents Preclinical Data on Molecular Glue Degrader MRT-6160 Targeting VAV1 for Autoimmune Diseases at AACR 2024

The company presented compelling preclinical findings for MRT-6160, a VAV1-targeting molecular glue degrader, at the American Association for Cancer Research (AACR) Annual Meeting, highlighting its potential for treating autoimmune diseases through selective VAV1 degradation....more

GlobeNewswireJanuary 2, 2024

Monte Rosa Therapeutics Appoints Silvia Buonamici, Ph.D. as Chief Scientific Officer

Monte Rosa Therapeutics announced the appointment of Silvia Buonamici, Ph.D., as its new Chief Scientific Officer, bringing deep expertise in oncology drug discovery and development to lead the company's research initiatives....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Monte Rosa Therapeutics, are just a search away.